5-[5-(1-benzylpyrrolidin-2-yl)-1,2,4-oxadiazol-3-yl]-2-(1H-imidazol-1-yl)pyridine



Compound IDCDAMM00159
Common name5-[5-(1-benzylpyrrolidin-2-yl)-1,2,4-oxadiazol-3-yl]-2-(1H-imidazol-1-yl)pyridine
IUPAC name5-(1-benzylpyrrolidin-2-yl)-3-(6-imidazol-1-ylpyridin-3-yl)-1,2,4-oxadiazole
Molecular formulaC21H20N6O

Experimental data

Retention time28.33
Adduct[M+H]+
Actual mz373.178
Theoretical mz373.177
Error1.52
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.3176

Identifiers and class information

Inchi keyCJAPLNIZVVYTIM-UHFFFAOYSA-N
SmilesC1CC(N(C1)CC2=CC=CC=C2)C3=NC(=NO3)C4=CN=C(C=C4)N5C=CN=C5
SuperclassBenzenoids
ClassBenzene and substituted derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)372.429
Computed dipole moment(dipole)7.392
Total solvent accessible surface area (SASA)698.543
Hydrophobic component of SASA (FOSA)166.824
Hydrophilic component of SASA (FISA)96.392
Pie component of the SASA (PISA)435.328
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1220.88
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)7.5
Free energy of solvation of dipole (dip^2/V)0.0447567
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.790837
Predicted polarizability in cubic angstroms (QPpolrz)45.579
Predicted hexadecane/gas partition coefficient (QPlogPC16)13.357
Predicted octanol/gas partition coefficient (QPlogPoct)19.892
Predicted water/gas partition coefficient (QPlogPw)11.963
Predicted octanol/water partition coefficient (QPlogPo/w)2.923
Predicted aqueous solubility (QPlogS)-3.982
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.814
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.719
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)301.106
Predicted brain/blood partition coefficient (QPlogBB)-0.186
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)149.55
Predicted skin permeability, log Kp (QPlogKp)-3.633
PM3 calculated ionization potential (IP(ev))9.29
PM3 calculated electron affinity (EA(eV))1.428
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)0.071
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)88.426
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)70.52
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P35228NOS2Nitric oxide synthase, inducibleT02703SEA
P41594GRM5Metabotropic glutamate receptor 5T99347SEA
P42785PRCPLysosomal Pro-X carboxypeptidaseT20371SEA
P55263ADKAdenosine kinaseT91661SEA
Q9NRA0SPHK2Sphingosine kinase 2T31989SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T99347DI0152Fragile X chromosome[ICD-11: LD55]P41594GRM5
T99347DI0331Parkinsonism[ICD-11: 8A00]P41594GRM5
T91661DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P55263ADK
T31989DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9NRA0SPHK2

Copyright © 2025